Australian Red Cross Blood Service

What Australian Red Cross Blood Service does

Australian Red Cross Lifeblood, formerly the Australian Red Cross Blood Service, is Australia's designated national blood authority operating as a division of the Australian Red Cross. Founded in 1996 and headquartered in Melbourne, the organization operates as a publicly funded nonprofit collecting, processing, testing, and distributing blood, plasma, and platelet products to hospitals and healthcare facilities across all Australian states and territories. Beyond core blood products, Lifeblood supplies pasteurised donor human milk for premature infants, faecal microbiota for transplant procedures, and maintains registration programs for organ, tissue, and blood stem cell donation.

The organization runs a national infrastructure comprising fixed donor centres, mobile blood collection units, processing centres, and testing laboratories providing specialized services including blood group/antigen/antibody testing, NIPT Massively Parallel Sequencing for fetal antigens, parvovirus B19 exposure testing, and transplantation immunogenetics. Donor-facing digital infrastructure includes the my.donateblood.com.au self-service portal for appointment booking and donation history, the Lifeblood Teams group donation platform covering all Australian jurisdictions, and the Lifeblood Gifts rewards program. Health professional-facing tools include the iTransfuse App for transfusion education and the High Ferritin App for therapeutic phlebotomy referrals.

Lifeblood's business model is government-funded under the National Blood Agreement rather than commercial. Donation services are provided free to donors, and revenue derives from federal and state government appropriations for blood product supply to public hospitals. Leadership is headed by CEO Stephen Cornelissen with a workforce of 1,001-5,000 employees. The organization holds a legal monopoly on Australia's national blood supply, reinforced by regulatory designation, national-scale physical infrastructure, and the Australian Red Cross brand equity built over decades of donor relationship management.

Name

Australian Red Cross Blood Service

Legal name

Australian Red Cross Lifeblood

Website

https://donateblood.com.au

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Blood Banking and Biological Product Supply

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH), Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)

Keywords

• Blood donation services
• Plasma collection supply
• Clinical blood components
• Donor milk program
• Faecal microbiota supply

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Blood Products Supply: As Australia's national blood authority, Australian Red Cross Lifeblood collects blood, plasma, and platelets from voluntary donors and supplies these biological products to hospitals and healthcare facilities across Australia. The service is government-funded and operates as a public health service rather than a commercial entity.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Australian Red Cross Lifeblood collects voluntary donations of blood, plasma, platelets, breast milk, and faecal microbiota, then processes and tests them at national processing centres and labs to produce clinical blood components, pasteurised donor human milk (PDHM), and faecal microbiota for transplant (FMT). These biological products are supplied to hospitals and healthcare professionals across Australia, supplemented by clinical education, transfusion guidelines, and donor-facing eligibility and booking services.

Product overview

Australian Red Cross Lifeblood operates as a unified national blood service providing multiple donation programs and blood products. The core offerings include blood, plasma, and platelets donation services through a donor portal (my.donateblood.com.au) and physical donor centers. Additional donation programs include breast milk, microbiome, organ and tissue, and blood stem cell donation. For health professionals, Lifeblood supplies blood components (red cells, platelets, plasma products, cryoprecipitate, serum eyedrops), faecal microbiota transplant products, fractionated plasma products, and pasteurised donor human milk. The organization also provides group donation through Lifeblood Teams, a rewards program via Lifeblood Gifts, and educational tools including the iTransfuse App for health professionals and the High Ferritin App for referring doctors.

Differentiator

Problem solved

Functional benefit

Brands

• Lifeblood Teams: Group blood donation program allowing organizations and friends to donate together
• Lifeblood Gifts
• Lifeblood Teams

Products and services

• Blood, Plasma and Platelets Donation Core donation service enabling eligible adult donors in Australia to give whole blood, plasma, or platelets at fixed donor centres or mobile collection units, with eligibility checks and appointment booking.
• Milk Donation Breast milk donation program for lactating mothers whose milk supports premature infants through the Pasteurised Donor Human Milk (PDHM) program.
• Microbiome Donation Faecal microbiota donation program where eligible donors supply stool samples for faecal microbiota for transplant (FMT) procedures.
• Organ and Tissue Donation Registration service for organ and tissue donation, connecting willing donors with patients in need across Australia.
• Blood Stem Cell Donation Registration program for blood stem cell donation to help patients requiring stem cell transplants.
• Blood Components for Health Professionals Clinical blood component products (red cells, platelets, fresh frozen plasma, cryodepleted plasma, cryoprecipitate, serum eyedrops, and modified components such as washed, frozen, irradiated, phenotyped, and split components) supplied to hospitals and health professionals.
• Faecal Microbiota for Transplant (FMT) Faecal microbiota transplant (FMT) product supplied to health professionals for treatment of recurrent Clostridioides difficile infection and other qualifying conditions.
• Fractionated Plasma Products Plasma-derived fractionated products including immunoglobulins such as IVIg, supplied to health professionals for medical treatments.
• Milk Program for Health Professionals Pasteurised Donor Human Milk (PDHM) supplied to hospital neonatal units for premature infant nutrition when maternal milk is unavailable or insufficient.
• Lifeblood Teams Group blood donation program allowing organisations, workplaces, and friend groups to form teams, donate together, and track collective donation activity.
• My Account Donor Portal Online donor self-service portal for booking appointments, checking eligibility, viewing donation history, and managing account details.

Quantifiable outcome

• Expected up to 20,000 additional donations annually from expanded eligibility criteria

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Vitalant: One of the largest US independent blood service organisations, operating a nationwide network of donor centres supplying blood components and specialty products to hospitals; comparable on collection scale, component manufacturing, and hospital distribution.
• American Red Cross Biomedical Services: The US counterpart under the Red Cross banner; collects and distributes approximately 40% of the US blood supply, operates a national donor network, and provides similar blood component manufacturing, testing, and hospital supply services.
• OneBlood: Large US regional blood collector serving the southeastern US; comparable in collection, processing, and hospital supply operations, though regional rather than national in scope.
• Canadian Blood Services: Canada's national, not-for-profit blood operator (excluding Quebec); collects blood, plasma, platelets, and operates the national stem cell registry and organ & tissue programs — a near-mirror of Lifeblood's mandate.
• Sanquin Blood Supply Foundation: The Netherlands' national blood bank, responsible for the entire Dutch blood supply; also operates diagnostic services and plasma-derived product manufacturing (Plasma Products division) — a strong European peer with both blood service and biopharma exposure.
• NHS Blood and Transplant: England's statutory national blood authority; provides an almost identical mandate of voluntary donor collection, blood component manufacturing, transplantation services, and specialist biological products (including a national cord blood bank).
• New Zealand Blood Service: New Zealand's national blood operator; collects and supplies blood and blood products, runs apheresis and plasma programs, and provides specialist tissue and stem cell services — directly comparable in scale and mandate.

Broad incumbents

• Australian Red Cross: Lifeblood's parent entity and broader humanitarian organisation; provides emergency response, international humanitarian programs, and community services beyond the blood mandate, making it comparable as the umbrella nonprofit rather than a direct operating peer.

Emerging players

• CSL Plasma: Global leader in plasma collection for fractionation into plasma-derived therapeutics; overlaps with Lifeblood's plasmapheresis operations and its fractionated plasma products line, though CSL focuses commercially on source plasma supply.
• Grifols: Vertically integrated plasma collector and fractionator (immunoglobulins, albumin, clotting factors); overlaps with Lifeblood's plasma collection and fractionated plasma product distribution activities, though as a commercial operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/redcrossbloodau
• YouTubeyoutube.com/lifebloodau
• Facebookfacebook.com/redcrossbloodau
• LinkedInlinkedin.com/company/the-australian-red-cross-blood-service
• Instagraminstagram.com/lifebloodau
• TikToktiktok.com/@lifebloodau

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Red Cross Blood Service